Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Nanosphere; Oxford BioDynamics, Janssen; Horizon Discovery; Eagle; Gentris

NEW YORK (GenomeWeb News) – Nanosphere this week received the CE IVD Mark for its Gram-Negative Blood Culture test that runs on the firm's Verigene molecular diagnostics platform. The Verigene BC-GN test provides rapid genus and species level detection for a broad panel of clinically significant gram-negative bacteria, said Nanosphere. It also detects critical genetic markers of antimicrobial resistance including KPC, NDM, CTX-M, OXA, VIM, and IMP.


Oxford BioDynamics said this week that it has signed an agreement to collaborate with Janssen Research & Development on developing epigenetic cancer biomarkers for circulating tumor cells. The firms will use Oxford's EpiSwitch platform for non-invasive detection of CTCs for diagnostic and prognostic stratification of prostate cancer patients.


Horizon Discovery has established two new centers of excellence for gene editing in Cambridge, UK. The new centers are at the Gurdon Institute, Cambridge University with Professor Steve Jackson, and the Cambridge Institute for Medical Research with Professor David Rubinsztein. Last week the firm announced it had established three new Centers of Excellence for gene editing in Asia.


UK bioinformatics firm Eagle announced that it has received ISO27001 certification, a standard of requirements and best practices for a systematic approach to managing company and customer information. The firm provides genomic analysis and data management services and helps customers move their existing bioinformatics systems to the cloud.


Gentris said this week that its Integrated Biorepository has been accredited by the College of American Pathologists. CAP established the biorepository accreditation program in 2011 to "help ensure consistent, industry-wide verification of biospecimen quality," said Gentris.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.